Description

Olieni 150mg Tablet (Olaparib) – Uses, Side Effects, Dosage & Price in Pakistan

Olieni 150mg Tablet (Olaparib) is an oral targeted cancer medicine containing olaparib, a PARP inhibitor. It is used in certain patients with ovarian, fallopian tube, primary peritoneal, breast, pancreatic, and prostate cancers when specific genetic or molecular characteristics make olaparib an appropriate treatment option.

Olaparib works by blocking PARP proteins, which help cells repair damaged DNA. Some cancer cells already have weaknesses in other DNA-repair pathways, such as those involving BRCA genes. Blocking PARP can make it harder for these cancer cells to repair DNA damage, which may contribute to cancer-cell death.

Olieni 150mg is a prescription oncology medicine. The appropriate indication, dose, treatment duration, and need for genetic or biomarker testing depend on the patient’s cancer type and treatment history. Treatment should therefore be started and monitored by a qualified oncologist.

Olieni 150mg Tablet (Olaparib) Used For

Olieni 150mg may be used as part of treatment or maintenance therapy for certain cancers in patients who meet the relevant clinical and molecular criteria.

Depending on the indication, olaparib may be used for:

• Certain BRCA-mutated advanced ovarian, fallopian tube, or primary peritoneal cancers as maintenance treatment after a response to platinum-based chemotherapy.
• Certain advanced ovarian, fallopian tube, or primary peritoneal cancers associated with homologous recombination deficiency (HRD), including use with bevacizumab in appropriate patients.
• Certain HER2-negative, germline BRCA-mutated metastatic breast cancers.
• Certain germline BRCA-mutated metastatic pancreatic adenocarcinoma as maintenance treatment after platinum-based chemotherapy.
• Certain BRCA-mutated or other eligible homologous recombination repair gene-mutated metastatic castration-resistant prostate cancers.

The exact approved indication depends on the patient’s cancer type, genetic test results, previous treatment, and local prescribing requirements.

How Olieni 150mg Tablet (Olaparib) Works

Olaparib belongs to a class of medicines called poly (ADP-ribose) polymerase inhibitors, commonly known as PARP inhibitors.

PARP enzymes help cells repair certain types of DNA damage. Cancer cells with particular defects in other DNA-repair pathways, including some BRCA-related cancers, may depend more heavily on PARP-mediated repair.

By inhibiting PARP, olaparib interferes with DNA repair in susceptible cancer cells. This can lead to accumulation of DNA damage and may prevent certain cancer cells from surviving and multiplying.

This mechanism is one reason genetic or biomarker testing may be important when determining whether olaparib is appropriate for a particular patient.

Olieni 150mg Dosage

The recommended olaparib tablet dose is commonly 300mg taken twice daily, with or without food, for approved indications where this regimen applies. Since each Olieni tablet contains 150mg olaparib, a 300mg dose corresponds to two 150mg tablets per dose.

However, the exact dose and treatment duration can vary according to the cancer indication, kidney function, other medicines, and adverse reactions. For patients with moderate renal impairment, the prescribing information recommends a reduced dose of 200mg twice daily.

Dose interruptions or reductions may be required when significant side effects occur.

Do not change the number of Olieni tablets you take without your oncologist’s instructions.

How to Take Olieni 150mg Tablet

Take Olieni exactly as prescribed by your oncologist. Olaparib tablets can be taken with or without food.

Swallow the tablets whole with water. Do not crush, chew, dissolve, or break the tablets unless your healthcare professional specifically provides an appropriate administration instruction.

Try to take the doses at approximately the same times each day.

If you miss a dose, do not take an extra dose to make up for it. Follow your doctor’s instructions and take the next dose at the scheduled time.

It is also important not to substitute olaparib tablets and capsules on a milligram-for-milligram basis because the formulations have different dosing and bioavailability characteristics.

Olieni 150mg Side Effects

Olieni 150mg may cause side effects, although not every patient experiences them. Common adverse reactions associated with olaparib include:

• Nausea
• Fatigue or weakness
• Anemia
• Vomiting
• Diarrhea
• Decreased appetite
• Headache
• Indigestion
• Constipation
• Changes in taste
• Muscle or joint pain
• Low white blood-cell counts
• Low platelet counts

Blood-test abnormalities can also occur during treatment, including reductions in hemoglobin, lymphocytes, leukocytes, neutrophils, or platelets. An increase in serum creatinine may also be observed.

Tell your healthcare professional if side effects are persistent, severe, or interfere with daily activities.

Serious Side Effects and Warnings

Olaparib can cause serious adverse reactions and requires appropriate medical monitoring.

Important warnings include:

• Myelodysplastic syndrome or acute myeloid leukemia (MDS/AML): Rare but serious blood and bone-marrow cancers have been reported. Persistent or unexplained blood-count abnormalities require medical evaluation.
• Pneumonitis: New or worsening cough, breathing difficulty, fever, or shortness of breath should be assessed promptly.
• Bone-marrow suppression: Anemia, neutropenia, thrombocytopenia, and other blood-cell abnormalities may occur.
• Embryo-fetal toxicity: Olaparib can cause fetal harm when used during pregnancy.
• Serious infection risk: Low blood-cell counts may increase susceptibility to certain infections.

The prescribing information recommends monitoring blood counts at baseline and regularly during treatment. If prolonged hematological toxicity occurs, treatment may need to be interrupted and further investigation may be required.

Seek prompt medical attention for severe breathing problems, unexplained bruising or bleeding, persistent fever, extreme weakness, or other serious symptoms.

Precautions Before Using Olieni 150mg

Before starting Olieni, tell your oncologist about your complete medical history and all medicines you currently use.

Special attention may be required if you have:

• Low blood-cell counts
• Previous chemotherapy-related bone-marrow problems
• Kidney impairment
• Lung disease
• Previous MDS or AML
• Pregnancy or plans to become pregnant
• Other serious medical conditions

Your doctor may perform blood tests before treatment and at regular intervals during therapy. Kidney function may also be assessed because dosage adjustment can be necessary in moderate renal impairment.

Olieni 150mg Drug Interactions

Olaparib is metabolized primarily through the CYP3A pathway. Strong or moderate CYP3A inhibitors can increase olaparib exposure, while strong or moderate CYP3A inducers can reduce exposure and potentially decrease its effectiveness.

Examples of medicines that may affect CYP3A include certain antifungal medicines, antibiotics, anticonvulsants, and other prescription drugs.

Because the interaction profile can be clinically important, tell your doctor about all prescription medicines, over-the-counter products, vitamins, and supplements you use.

Do not start a new medicine or herbal supplement without discussing it with your healthcare professional.

Olieni 150mg During Pregnancy

Olieni 150mg may cause harm to a developing fetus. Women who can become pregnant should discuss effective contraception with their healthcare provider before starting treatment.

If pregnancy occurs while taking olaparib, contact the treating oncologist promptly to discuss the potential risks and appropriate medical care.

Breastfeeding should also be discussed with a healthcare professional. The prescribing information advises women not to breastfeed during olaparib treatment and for the recommended period after the final dose.

Olieni 150mg Monitoring

Regular monitoring is an important part of olaparib treatment. Depending on the patient’s condition, the healthcare team may monitor:

• Complete blood counts
• Hemoglobin levels
• White blood-cell counts
• Platelet counts
• Kidney function
• Signs of infection
• Breathing symptoms
• Treatment response
• Symptoms that could indicate serious bone-marrow complications

Blood counts are particularly important because olaparib can cause significant hematological adverse reactions. Persistent abnormalities may require treatment interruption or further investigation.

Olieni 150mg Tablet Storage

Store Olieni 150mg according to the storage instructions provided with the specific product packaging.

Keep the tablets in their original container and protect them from excessive heat, moisture, and unsuitable environmental conditions.

Keep Olieni out of reach of children and do not use the medicine after the expiry date printed on the packaging.

Because Olieni is a prescription oncology medicine, patients should also follow any storage instructions supplied by the manufacturer or pharmaceutical supplier.

Olieni 150mg Price in Pakistan

The Olieni 150mg Tablet price in Pakistan can vary depending on product availability, imported stock, supplier, pack size, and market conditions. Oncology medicines may have changing prices because of import and supply-related factors.

For the latest Olieni 150mg price in Pakistan, customers can contact Impo Medic to confirm the currently available product, pack details, and price before ordering.

How to Buy Olieni 150mg Tablet in Pakistan

Patients looking for Olieni 150mg Tablet (Olaparib) in Pakistan should obtain this prescription oncology medicine from a reliable pharmaceutical supplier and use it only according to an oncologist’s prescription.

Before purchasing, check the medicine name, strength, packaging, batch information, expiry date, and storage conditions. Because olaparib is prescribed for specific cancer types and molecular characteristics, patients should not start treatment without appropriate medical evaluation.

Impo Medic can be contacted to check the current availability and price of Olieni 150mg Tablet in Pakistan.

Frequently Asked Questions About Olieni 150mg Tablet (Olaparib)

What is Olieni 150mg Tablet (Olaparib) used for?

Olieni contains olaparib, a PARP inhibitor used for certain ovarian, fallopian tube, primary peritoneal, breast, pancreatic, and prostate cancers in patients who meet the relevant clinical and molecular criteria.

How many Olieni 150mg tablets are taken per day?

For many approved adult indications, the standard olaparib tablet dose is 300mg twice daily, which equals two 150mg tablets per dose. However, the prescribed dose can be reduced for kidney impairment, drug interactions, or certain side effects.

Can Olieni 150mg be taken with food?

Yes. Olaparib tablets can generally be taken with or without food.

What are the common Olieni 150mg side effects?

Common side effects include nausea, fatigue, anemia, vomiting, diarrhea, decreased appetite, headache, constipation, muscle or joint pain, and changes in blood-cell counts.

Is Olieni 150mg a chemotherapy medicine?

Olieni contains olaparib, which is a targeted PARP inhibitor rather than traditional cytotoxic chemotherapy. It works by interfering with DNA-repair processes in susceptible cancer cells.

Does Olieni 150mg require genetic testing?

For several approved uses, treatment selection depends on specific genetic or molecular characteristics such as BRCA mutations or homologous recombination deficiency. The required testing depends on the cancer indication.

Can I buy Olieni 150mg Tablet in Pakistan?

Availability and price can vary for imported oncology medicines. You can contact Impo Medic to check the current availability and price of Olieni 150mg Tablet in Pakistan.